< Back to companies

InterAx developed a drug discovery and optimisation technology platform to go beyond target identification and ligand discovery. It is connecting AI and cell signalling to design drugs triggering a precisely defined cell pathway modulation. This unique combination enables to identify and optimise safer and more efficacious drug candidates rather than just generating them faster and cheaper, thus significantly de-risk their development process. InterAx focuses on the design of drugs targeting G-Protein-Coupled Receptors, the largest class of human cellular receptors and targets of 40% of all marketed. InterAx offers biopharma partners in need to gain in-depth insight for the design of high-quality drug candidates access to its technology platform.

Share
Shareable draft
Get Involved in InterAx Biotech

Company Info

Founded
2016
Website
interaxbiotech.com/

Categories

Drug DiscoveryAI drug discoveryDrug Discovery/DevelopmentAI / ML

Disease Areas

Technologies

Computational BiologyDrug DesignAI-driven Drug DiscoveryPharmacology Platforms
Only accessible to MedStartr community members. Join now

What do you think of InterAx Biotech?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in InterAx Biotech
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free